Biological markers of cocaine addiction: Implications for medications development

Addiction Biology

Volumn 8, Issue 2, 2003, Pages 123-139

  Elkashef, Ahmed ^a   Vocci, Frank ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BIOLOGICAL MARKER; BROMOCRIPTINE; CITALOPRAM; DESIPRAMINE; DOPAMINE 2 RECEPTOR; HUMAN GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; TESTOSTERONE;

ADULT; BRAIN MAPPING; COCAINE DEPENDENCE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW;

ADRENOCORTICOTROPIC HORMONE; BIOLOGICAL MARKERS; COCAINE-RELATED DISORDERS; DOPAMINE AGONISTS; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; EVENT-RELATED POTENTIALS, P300; EYE MOVEMENTS; FRONTAL LOBE; HOMOVANILLIC ACID; HUMAN GROWTH HORMONE; HUMANS; LUTEINIZING HORMONE; METHOXYHYDROXYPHENYLGLYCOL; PROLACTIN; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037810438     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/1355621031000117356     Document Type: Review

References (69)

1. Lima MS, Reisser AAP, Soares BGO, Farrell M. Antidepressants for cocaine dependence (Cochrane Review). The Cochrane Library, Issue 1,2002. Oxford: Update Software Ltd.
2. Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E. Acute effects of cocaine on plasma adenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther 1992;263:505-9.
3. Rothman RB, Gorelick DA, Baumann MH, et al. Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies. Pharmacol Biochem Behav 1994;49:583-8.
4. Elangovan N, Barbato M, Cooper T, Winsberg B. Neurohormonal and behavioral response to methylphenidate in cocaine abstinence. Psychiatry Res 1996;65:65-71.
5. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry 1995;38:751-5.
6. Gawin FH, Kleber HD. Neuroendocrine findings in a chronic cocaine abusers: a preliminary report. Br J Psychiatry 1985;147:569-73.
7. Swartz CM, Breen K, Leone F. Serum prolactin levels during extended cocaine abstinence. Am J Psychiatry 1990;147:777-9.
8. Knoblich G, Curtis D, Faustman WO, et al. Increased CSF HVA with craving in long-term abstinent cocaine abusers. Biol Psychiatry 1992;32:96-100.
9. Weiss RD, Hufford C, Mendelson JH. Serum prolactin levels and treatment outcome in cocaine dependence. Sc Biol Psychiatry 1994;35:573-4.
10. Kranzler HR, Wallington DJ. Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients. Am J Drug Alcohol Abuse 1992;18:187-95.
11. Faraj BA, Camp VM, Davis DC, Kutner M, Cotsonis GA, Holloway T. Elevated concentrations of dopamine sulfate in plasma of cocaine abusers. Biochem Pharmacol 1993;46:1453-7.
12. Alper KR, Prichep LS, Kowalik S, Rosenthal MS, Roy John E. Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 1998;19:1-9.
13. King DE, Herning RI, Gorelick DA, Cadet JL. Gender differences in the EEG of abstinent cocaine abusers. Neuropsychobiology 2000;42:93-8.
14. Herning RI, Guo X, Better WE, et al. Neurophysiological signs of cocaine dependence: increased electroencephalogram beta during withdrawal. Biol Psychiatry 1997;4:1087-94.
15. Herning RI, King DE. EEG and evoked potentials alterations in cocaine-dependent individuals. NIDA Res Monogr 1996;163:203-23.
16. Prichep LS, Alper K, Kowalik SC, Rosenthal M. Neurometric QEEG studies of crack cocaine dependence and treatment outcome. J Addict Dis 1996;15:39-53.
17. Prichep LS, Alper KR, Kowalik HM, MeeLee T, John ER, Rosenthal MS. Quantitative electroencephalographic characteristics of crack cocaine dependence. Biol Psychiatry 1996;40:986-93.
18. Prichep LS, Kowalik SC, Alper K, de Jesus C. Quantitative EEG characteristics of children exposed in utero to cocaine. Clin Electroencephalogr 1995;26:166-72.
19. Noldy NE, Santos CV, Politzer N, Blair RD, Carlen PL. Quantitative EEG changes in cocaine withdrawal: evidence for long-term CNS effects. Neuropsychobiology 1994;30:189-96.
20. Herning RI, Glover BJ, Koeppl B, Phillips RL, London ED. Cocaine-induced increases in EEG alpha and beta activity: evidence for reduced cortical processing. Neuropsychopharmacology 1994;11:1-9.
21. Bauer LO. Frontal P300 decrements, childhood conduct disorder, family history, and the prediction of relapse among abstinent cocaine abusers. Drug Alcohol Depend 1997;44:1-10.
22. Bauer LO. Psychomotor and electroencephalographic sequelae of cocaine dependence. NIDA Res Monogr 1996;163:66-93.
23. Fein G, Biggins C, MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry 1996;39:955-65.
24. Bauer LO, Mott AE. Differential effects of cocaine, alcohol, and nicotine dependence on olfactory evoked potentials. Drug Alcohol Depend 1996;42:21-6.
25. Bauer LO, Easton C. Pattern shift visual evoked potentials in abstinent cocaine-dependent, alcohol-dependent, and cross-dependent patients. Drug Alcohol Depend 1996;40:203-9.
26. Levin JM, Holman BL, Mendelson JH, et al. Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med 1994;35:1902-9.
27. Prichep LS, Alper AR, Sverdlov L, et al. Outcome related electrophysiological subtypes of cocaine dependence. Clinical Electroencephalogr 2002;33:8-20.
28. Rosse RB, Risher-Flowers D, Peace T, Deutsch SI. Evidence of impaired smooth pursuit eye movement performance in crack cocaine users. Biol Psychiatry 1992;31:1238-40.
29. Strickland TL, Mena I, Villanueva-Meyer J, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1993;5:419-27.
30. Volkow ND, Wang GJ, Fowler JS, et al. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 1996;14:159-68.
31. Volkow ND, Fowler JS, Wolf AP, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991;148:621-6.
32. Volkow ND, Fowler JS, Wolf AP, et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990;147:719-24.
33. Christensen JD, Kaufman MJ, Levin JM, et al. Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med 1996;35:658-63.
34. MacKay S, Meyerhoff DJ, Dillon WP, Weiner MW, Fein G. Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers. Biol Psychiatry 1993;15:261-4.
35. Volkow ND, Wang GJ, Fowler JS, et al. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 1999;156:9.
36. Berggren U, Eriksson M, Fahlke C, Balldin J. relationship between central serotonergic neurotranmisson and reduction in alcohol intake by citalopram. Drug Alcohol Depend 2001;63:263-7.
37. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985;9:469-77.
38. Cocores JA, Dackis CA, Gold MS. Sexual dysfunction secondary to cocaine abuse in two patients. J Clin Psychiatry 1986;47:7.
39. Mendelson JH, Teoh SK, Lange U, et al. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry 1988;145:1094-8.
40. Demer JL, Volkow ND, Ulrich I, Krajewski K, Davis CM, Porter FI. Eye movements in cocaine abusers. Psychiatry Res 1989;29:123-36.
41. Martin SD, Yeragani VK, Lodhi R, Galloway MP. Clinical ratings and plasma HVA during cocaine abstinence. Biol Psychiatry 1989;26:356-62.
42. Lee MA, Bowers MM, Nash JF, Meltzer HY. Neuroendocrine measures of dopaminergic function in chronic cocaine users. Psychiatry Res 1990;33:151-9.
43. Satel SL, Price LH, Palumbo JM, et al. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective in patient study. Am J Psychiatry 1991;148:1712-16.
44. Rosse RB, McCarthy MF, Alim TN, Deutsch SI. Saccadic distractibility in cocaine dependent patients: a preliminary laboratory exploration of the cocaine-OCD hypothesis. Drug Alcohol Depend 1994;35:25-30.
45. Rosse RB, Johri S, Kendrick K, et al. Preattentive and attentive eye movements during visual scanning of a cocaine cue: correlation with intensity of cocaine cravings. J Neuropsychiatry Clin Neurosci 1997;9:91-3.
46. Bauer LO. Eye movements in recovering substance abusers: a prospective study. Addict Behav 1993;18:465-72.
47. Roy M, Roy A, Smelson D, Brown S, Weinberger L. Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication. Biol Psychiatry 1997;42:631-3.
48. Roy M, Smelson DA, Roy A. Abnormal electroretinogram in cocaine-dependent patients. Relationship to craving. Br J Psychiatry 1996;168:507-11.
49. Smelson DA, Roy A, Roy M. The electroretinogram and neuropsychological functioning in cocaine addicts [letter]. Can J Psychiatry 1996;6:415.
50. Manschreck TC, Schneyer ML, Weisstein CC, et al. Freebase cocaine and memory. Compr Psychiatry 1990;31:369-75.
51. O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse 1992;18:131-44.
52. Berry J, Van Gorp WG, Herzberg DS, et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 1993;32:231-7.
53. Roberts LA, Bauer LO. Reaction time during cocaine versus alcohol withdrawal: longitudinal measures of visual and auditory suppression. Psychiatry Res 1993;46:229-37.
54. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 1995;37:247-53.
55. Rosselli M, Ardila A. Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 1996;18:122-35.
56. Easton C, Bauer LO. Neuropsychological correlates of urine toxicology results. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:969-82.
57. Hoff AL, Riordan H, Morris L, et al. Effects of crack cocaine on neurocognitive function. Psychiatry Res 1996;60:167-76.
58. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999;11:361-9.
59. Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF. PET study of competition between intravenous cocaine and [11C] raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997;154:1209-13.
60. Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;4:827-30.
61. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997;24:830-3.
62. Volkow ND, Hitzemann R, Wang GJ, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992;11:184-90.
63. London ED, Cascella NG, Wong DF, et al. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 1990;47:567-74.
64. Baxter LR Jr, Schwartz JM, Phelps ME, et al. Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiatry 1988;(Suppl 49):23-6.
65. Wallace EA, Wisniewski G, Zubal G, et al. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl) 1996;128:17-20.
66. Malison RT, Best SE, Wallace EA, et al. Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology (Berl) 1995;122:358-62.
67. Mena I, Giombetti RJ, Miller BL, et al. Cerebral blood flow changes with acute cocaine intoxication: clinical correlations with SPECT, CT, and MRI. NIDA Res Monogr 1994;138:161-73.
68. Holman BL, Mendelson J, Garada B, et al. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J Nucl Med 1993;34:723-7.
69. Holman BL, Carvalho PA, Mendelson J, et al. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. J Nucl Med 1991;32:1206-10.